Nelarabine
NDC 70771-1685, Nelarabine, injection, from Zydus Lifesciences Limited.
- Product NDC
- 70771-1685
- Status
- Listed
- Labeler
- Zydus Lifesciences Limited
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA215037
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1685 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NELARABINE5 mg/mL
Pharmacologic classes
Nucleic Acid Synthesis Inhibitors [MoA]; Nucleoside Metabolic Inhibitor [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70771-1685-1 | 70771168501 | 1 VIAL in 1 CARTON (70771-1685-1) / 50 mL in 1 VIAL |
| 70771-1685-8 | 70771168508 | 6 VIAL in 1 CARTON (70771-1685-8) / 50 mL in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/877b69a0-0899-455d-926e-f5a7478c31f8
Use it
Look up 70771-1685 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1685 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70771-1685. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.